Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,900 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2022) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 6MB, 247 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 224 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is E  [Clear All Filters]
2021
S. Livingstone, Morales, D. R., Donnan, P. T., Payne, K., Thompson, A. J., Youn, J. H., and Guthrie, B., “Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study”, Lancet Healthy Longev, vol. 2, pp. e352-e361, 2021.
M. Povey, Aris, E., Cheuvart, B., Hall, G., Cohet, C., and Willame, C., “Effectiveness of "Priorix" Against Measles and Mumps Diseases in Children Born After 2004 in the United Kingdom: A Retrospective Case-control Study Using the Clinical Practice Research Datalink GOLD Database”, Pediatr Infect Dis J, vol. 40, pp. 590-596, 2021.
B. Ehlken, Nishikawa, C., Kaplan, S., Dresco, I., Granados, D., and Toussi, M., “Effectiveness of risk minimisation measures for valproate: a drug utilisation study based on implementation of a Risk Minimisation Programme in Europe, analysis of data from the UK”, Curr Med Res Opin, pp. 1-20, 2021.
M. J. Carr, Steeg, S., Webb, R. T., Kapur, N., Chew-Graham, C. A., Abel, K. M., Hope, H., Pierce, M., and Ashcroft, D. M., “Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study”, Lancet Public Health, vol. 6, pp. e124-e135, 2021.
A. A. Matthews, S. Hinton, P., Stanway, S., Lyon, A. R., Smeeth, L., Lund, J. L., and Bhaskaran, K., “Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors”, Heart, vol. 107, pp. 1327-1335, 2021.
F. Bianic, Guelfucci, F., Robin, L., Martre, C., Game, D., and Bockenhauer, D., “Epidemiology of Distal Renal Tubular Acidosis: A Study Using Linked UK Primary Care and Hospital Data”, Nephron, pp. 1-10, 2021.
S. S. Jick, Oleske, D. M., Persson, R., Zamudio, J., and Facheris, M. F., “Epidemiology of skin event rates among users of pumps for the subcutaneous administration of drugs for chronic conditions”, Curr Med Res Opin, pp. 1-9, 2021.
G. Wojewodka, Gulliford, M. C., Ashworth, M., Richardson, M. P., and Ridsdale, L., “Epilepsy and mortality: a retrospective cohort analysis with a nested case-control study identifying causes and risk factors from primary care and linkage-derived data”, BMJ Open, vol. 11, p. e052841, 2021.
D. Yu, Peat, G., Jordan, K. P., Bailey, J., Prieto-Alhambra, D., Robinson, D. E., Strauss, V. Y., Walker-Bone, K., Silman, A., Mamas, M., Blackburn, S., Dent, S., Dunn, K., Judge, A., Protheroe, J., and Wilkie, R., “Estimating the population health burden of musculoskeletal conditions using primary care electronic health records”, Rheumatology (Oxford), 2021.
M. Alexandridou, Cattaert, T., and Verstraeten, T., “Estimation of Risk of Death Attributable to Acute Gastroenteritis Not Caused by Clostridioides difficile Infection Among Hospitalized Adults in England”, Clin Epidemiol, vol. 13, pp. 309-315, 2021.
M. D. Danese, Pemberton-Ross, P., Catterick, D., and Villa, G., “Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom”, Eur J Prev Cardiol, vol. 28, pp. 335-343, 2021.
J. Davidson, Banerjee, A., Mathur, R., Ramsay, M., Smeeth, L., Walker, J., McDonald, H., and Warren-Gash, C., “Ethnic differences in the incidence of clinically diagnosed influenza: an England population-based cohort study 2008-2018”, Wellcome Open Res, vol. 6, p. 49, 2021.
Y. V. Chudasama, Zaccardi, F., Coles, B., Gillies, C. L., Hvid, C., Seidu, S., Davies, M. J., and Khunti, K., “Ethnic, social and multimorbidity disparities in therapeutic inertia: a UK primary care observational study in patients newly diagnosed with type 2 diabetes”, Diabetes Obes Metab, 2021.
R. Caleyachetty, Barber, T. M., Mohammed, N. I., Cappuccio, F. P., Hardy, R., Mathur, R., Banerjee, A., and Gill, P., “Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study”, Lancet Diabetes Endocrinol, 2021.
C. Cabrera, Quelen, C., Ouwens, M., Hedman, K., Rigney, U., and Quint, J. K., “Evaluating a Cox marginal structural model to assess the comparative effectiveness of inhaled corticosteroids versus no inhaled corticosteroid treatment in chronic obstructive pulmonary disease”, Ann Epidemiol, 2021.
W. Y. Khawagi, Steinke, D., Carr, M. J., Wright, A. K., Ashcroft, D. M., Avery, A., and Keers, R. N., “Evaluating the safety of mental health-related prescribing in UK primary care: a cross-sectional study using the Clinical Practice Research Datalink (CPRD)”, BMJ Qual Saf, 2021.
Y. Li, Kurinczuk, J. J., Gale, C., Siassakos, D., and Carson, C., “Evidence of disparities in the provision of the maternal postpartum 6-week check in primary care in England, 2015-2018: an observational study using the Clinical Practice Research Datalink (CPRD)”, J Epidemiol Community Health, 2021.
A. Banerjee, Chen, S., Pasea, L., Lai, A. G., Katsoulis, M., Denaxas, S., Nafilyan, V., Williams, B., Wong, W. K., Bakhai, A., Khunti, K., Pillay, D., Noursadeghi, M., Wu, H., Pareek, N., Bromage, D., McDonagh, T. A., Byrne, J., Teo, J. T. H., Shah, A. M., Humberstone, B., Tang, L. V., Shah, A. S. V., Rubboli, A., Guo, Y., Hu, Y., Sudlow, C. L. M., Lip, G. Y. H., and Hemingway, H., “Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic”, Eur J Prev Cardiol, 2021.
2020
T. Galvain, Chitnis, A., Paparouni, K., Tong, C., Holy, C. E., and Giannoudis, P. V., “The economic burden of infections following intramedullary nailing for a tibial shaft fracture in England”, BMJ Open, vol. 10, p. e035404, 2020.
O. Moussa, Ardissino, M., Heaton, T., Tang, A., Khan, O., Ziprin, P., Darzi, A., Collins, P., and Purkayastha, S., “Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study”, Eur Heart J, 2020.
G. H. B. Greenhall, Mansfield, K. E., Nitsch, D., Iwagami, M., Leyrat, C., Johnston, R., Smeeth, L., and Tomlinson, L. A., “The effect of initiation of renin-angiotensin system inhibitors on haemoglobin: A national cohort study”, Br J Clin Pharmacol, 2020.
M. Carney, Quiroga, M., Mounce, L., Shephard, E., Hamilton, W., and Price, S., “Effect of pre-existing conditions on bladder cancer stage at diagnosis: a cohort study using electronic primary care records in the UK”, Br J Gen Pract, 2020.
T. P. van Staa, Palin, V., Li, Y., Welfare, W., Felton, T. W., Dark, P., and Ashcroft, D. M., “The effectiveness of frequent antibiotic use in reducing the risk of infection-related hospital admissions: results from two large population-based cohorts”, BMC Med, vol. 18, p. 40, 2020.
G. Nakafero, Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-Tam, J. S., and Abhishek, A., “Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs”, Rheumatology (Oxford), 2020.
T. Tran, Assayag, D., Ernst, P., and Suissa, S., “Effectiveness of proton pump inhibitors in idiopathic pulmonary fibrosis: a population-based cohort study”, Chest, 2020.
S. S. Zghebi, Steinke, D. T., Rutter, M. K., and Ashcroft, D. M., “Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data”, BMJ Open, vol. 10, p. e033866, 2020.
R. Ravindrarajah, Reeves, D., Howarth, E., Meacock, R., Soiland-Reyes, C., Cotterill, S., Whittaker, W., Heller, S., Sutton, M., Bower, P., and Kontopantelis, E., “Epidemiology and determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus, 2000-2015: cohort population study using UK electronic health records”, BMJ Open, vol. 10, p. e040201, 2020.
Y. Ye, Jiang, B., Manne, S., Moses, P. L., Almansa, C., Bennett, D., Dolin, P., and Ford, A. C., “Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom”, Gut, 2020.
F. N. Mirza, Yumeen, S., and Walter, F. M., “The Epidemiology of Malignant Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma in the United Kingdom from 2004-2014: A Population-Based Cohort Analysis using the Clinical Practice Research Datalink”, Br J Dermatol, 2020.
J. D. Pauling, McGrogan, A., Snowball, J., and McHugh, N. J., “Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink”, Rheumatology (Oxford), 2020.
A. G. Lai, Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B., Pillay, D., Noursadeghi, M., Linch, D., Hughes, D., Forster, M. D., Turnbull, C., Fitzpatrick, N. K., Boyd, K., Foster, G. R., Enver, T., Nafilyan, V., Humberstone, B., Neal, R. D., Cooper, M., Jones, M., Pritchard-Jones, K., Sullivan, R., Davie, C., Lawler, M., and Hemingway, H., “Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study”, BMJ Open, vol. 10, p. e043828, 2020.
A. Banerjee, Pasea, L., Harris, S., Gonzalez-Izquierdo, A., Torralbo, A., Shallcross, L., Noursadeghi, M., Pillay, D., Sebire, N., Holmes, C., Pagel, C., Wong, W. K., Langenberg, C., Williams, B., Denaxas, S., and Hemingway, H., “Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study”, Lancet, vol. 395, pp. 1715-1725, 2020.
M. D. Danese, Pemberton-Ross, P., Catterick, D., and Villa, G., “Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom”, Eur J Prev Cardiol, p. 2047487319899212, 2020.
R. Mathur, Palla, L., Farmer, R. E., Chaturvedi, N., and Smeeth, L., “Ethnic differences in the severity and clinical management of type 2 diabetes at time of diagnosis: A cohort study in the UK Clinical Practice Research Datalink”, Diabetes Res Clin Pract, vol. 160, p. 108006, 2020.
R. Mathur, Farmer, R. E., Eastwood, S. V., Chaturvedi, N., Douglas, I., and Smeeth, L., “Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study”, PLoS Med, vol. 17, p. e1003106, 2020.
E. M. Heintjes, Bezemer, I. D., Prieto-Alhambra, D., Smits, E., Booth, H. P., Dedman, D., He, Y., Hoti, F., Vehkala, M., de Vogel, S., Robinson, N. J., Appenteng, K., and van Beest, F. J. A. Penn, “Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries”, Clin Epidemiol, vol. 12, pp. 423-433, 2020.
R. Palladino, Marrie, R. A., Majeed, A., and Chataway, J., “Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England”, JAMA Neurol, 2020.
Y. Li, Sperrin, M., Martin, G. P., Ashcroft, D. M., and van Staa, T. P., “Examining the impact of data quality and completeness of electronic health records on predictions of patients' risks of cardiovascular disease”, Int J Med Inform, vol. 133, p. 104033, 2020.
2019
O. M. Moussa, Ardissino, M., Kulatilake, P., Faraj, A., Muttoni, E., Darzi, A., Ziprin, P., Scholtz, S., and Purkayastha, S., “Effect of body mass index on depression in a UK cohort of 363 037 obese patients: A longitudinal analysis of transition”, Clin Obes, p. e12305, 2019.
G. S. Matharu, Mouchti, S., Twigg, S., Delmestri, A., Murray, D. W., Judge, A., and Pandit, H. G., “The effect of smoking on outcomes following primary total hip and knee arthroplasty: a population-based cohort study of 117,024 patients”, Acta Orthop, pp. 1-9, 2019.
M. J. Cook, Sorial, A. K., Lunt, M., Board, T. N., and O'Neill, T. W., “Effect of timing and duration of statin exposure on risk of hip or knee revision arthroplasty: a population-based cohort study”, J Rheumatol, 2019.
M. C. Gulliford, Prevost, A. T., Charlton, J., Juszczyk, D., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M. V., Yardley, L., and Ashworth, M., “Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial”, Bmj, vol. 364, p. l236, 2019.
K. Marinier, Macouillard, P., de Champvallins, M., Deltour, N., Poulter, N., and Mancia, G., “Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, 2019.
K. Mattishent, Richardson, K., Dhatariya, K., Savva, G. M., Fox, C., and Loke, Y. K., “The effects of hypoglycemia and dementia on cardiovascular events, falls and fractures and all-cause mortality in older people - a retrospective cohort study”, Diabetes Obes Metab, 2019.
M. C. Gulliford, Juszczyk, D., Prevost, A. T., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M., Yardley, L., Ashworth, M., and Charlton, J., “Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study”, Health Technol Assess, vol. 23, pp. 1-70, 2019.
E. Herrett, Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., Van Staa, T., Sofat, R., Timmis, A., and Smeeth, L., “Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study”, Lancet, 2019.
H. Whittaker, Connell, O., Campbell, J., Elbehairy, A. F., Hopkinson, N. S., and Quint, J. K., “Eligibility for Lung Volume Reduction Surgery in Chronic Obstructive Pulmonary Disease patients identified in a UK primary care setting”, Chest, 2019.
R. Ferguson, Culliford, D., Prieto-Alhambra, D., Pinedo-Villanueva, R., Delmestri, A., Arden, N., and Bowen, C., “Encounters for foot and ankle pain in UK primary care: a population-based cohort study of CPRD data”, Br J Gen Pract, vol. 69, pp. e422-e429, 2019.
L. Horne, Ashfaq, A., MacLachlan, S., Sinsakul, M., Qin, L., LoCasale, R., and Wetmore, J. B., “Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England”, BMC Nephrol, vol. 20, p. 85, 2019.
S. Wood, Marchant, A., Allsopp, M., Wilkinson, K., Bethel, J., Jones, H., and John, A., “Epidemiology of eating disorders in primary care in children and young people: a Clinical Practice Research Datalink study in England”, BMJ Open, vol. 9, p. e026691, 2019.
[Page last reviewed 4 January 2022]